CPC C12N 15/1135 (2013.01) [A61P 35/04 (2018.01); C12N 15/86 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12N 2740/15043 (2013.01)] | 3 Claims |
1. A medication for inhibiting metastasis and invasion of breast cancer, comprising shRNAs for inhibiting expression of human LINC01614, wherein the shRNAs for inhibiting expression of human LINC01614 comprises a shRNA-1 and/or a shRNA-2, a sense strand nucleotide sequence of the shRNA-1 is shown as SEQ ID No. 3, an antisense strand nucleotide sequence of the shRNA-1 is shown as SEQ ID No. 4, a sense strand nucleotide sequence of the shRNA-2 is shown as SEQ ID No. 5, and an antisense strand nucleotide sequence of the shRNA-2 is shown as SEQ ID No. 6.
|